"Advanced Rheumatology of Houston offers the highest-quality health care for patients with rheumatologic conditions. Dr. Brionez has more than 10 years of experience diagnosing and treating conditions like rheumatoid arthritis, osteoporosis, and lupus. The clinic’s on-site lab and infusion services help patients live more comfortable lives. Give the clinic a call or visit the website for more information."

During the past decade, Advanced Rheumatology of Houston conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Rheumatology of Houston" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "R-Pharm International, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Rheumatology of Houston" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "OCT Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Rheumatology of Houston" are "Arthritis, Psoriatic" (3 trials), "Systemic Lupus Erythematosus" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Advanced Rheumatology of Houston" in a lesser frequency.

Most popular intervention types in "Advanced Rheumatology of Houston" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "Guselkumab" (2 trials), "Apremilast (CC-10004)" (1 trials) and "Apremilast (CC-10004) Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Rheumatology of Houston" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Rheumatology of Houston". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Advanced Rheumatology of Houston, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Rheumatology of Houston, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".